Dimethyl Sulfoxide: Clinical Trials

31 trials of Dimethyl Sulfoxide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed, 8 unknown, 4 terminated, 2 not yet recruiting. 10 Phase 2, 9 Not applicable, 7 Phase 1, 5 Phase 3, 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 210Completed 4, Unknown 4, Not yet recruiting 1, Terminated 1
Not applicable9Completed 5, Unknown 3, Not yet recruiting 1
Phase 17Completed 5, Recruiting 1, Terminated 1
Phase 35Completed 2, Not yet recruiting 1, Terminated 1, Unknown 1
Phase 43Completed 2, Terminated 1
Early Phase 12Completed 1, Unknown 1

Follow Dimethyl Sulfoxide: new trials by email Literature Review of Dimethyl Sulfoxide trials Research Report on Dimethyl Sulfoxide

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Stop Air Leak by Talc or Autologous Blood Patch Therapy
talc powder, patient's own venous blood - Pneumothorax Spontaneous Secondary
Phase 2 / Phase 3Not yet recruitingChinese University of Hong Kong302026-11-012026-09-04
Effect of Local Use of Vitamin D on the Rate of Canine Distillization: a Split Mouth Randomized Control Trial
Experimental: 1,25 DHC injection, Placebo: plain DMSO solvent - Malocclusion of Anterior Teeth
Phase 1RecruitingFoundation University Islamabad302026-02-202026-03-18
Bond Strength Evaluation
dimethyl sulfoxide, Cholorhexidine - Bonding
Not applicableCompletedAl-Azhar University302025-11-012026-08-12
Clinical Evaluation of Dimethyl Sulfoxide Wet Bonding Technique
Universal single bond adhesive, DMSO - Dimethyl Sulfoxide
Not applicableNot yet recruitingManipal University College Malaysia682024-10-202024-10-10
Impact of Dentin Pretreatment With Dimethyl Sulfoxide on Behavior of Resin Composite Restorations in Non-Carious Cervical Lesions
Dimethyl sulfoxide (DMSO), NO dimethyl sulfoxide - Class V Non-carious Cervical Dental Lesions
Not applicableCompletedMansoura University302023-12-152026-09-22
Topical Ascorbic Acid for Treatment of Squamous Cell Skin Cancer
30% ascorbic acid in DMSO - Squamous Cell Cancer, Squamous Cell Carcinoma
Early Phase 1UnknownCenter for Biomedical Research, Inc.152023-06-122023-08-30
Endovascular Embolization of Chronic Subdural Hematomas After Surgery
Post surgical embolization of middle meningeal artery with liquid embolic agents (ethylene vinyl alcohol copolymers as Onix, Squid, Phil or Libro) - Chronic Subdural Hematoma
Not applicableUnknownHospital Universitari Vall d'Hebron Research Institute2802022-02-112022-03-21
Acceleration of Orthodontic Tooth Movement
Dihydroxycholecalciferols, dimethyl sulfoxide, serum - Mild to Moderate Anterior Mandibular Segment Crowdind
Phase 2 / Phase 3CompletedLatakia University182021-09-202022-09-30
Clinical Evaluation of Dimethyl Sulfoxide Dentin Pre-treatment
Dimethyl Sulfoxide, 3M ESPE Single bond 2, Filtek Z350 XT, 3 M ESPE, St Paul, MN, USA) - Dental Diseases
Not applicableCompletedCairo University242020-11-172023-02-09
Melatonin Cream Against Acute Radiation Dermatitis in Patients With Early Breast Cancer
Melatonin, Dimethyl Sulfoxide, Placebos - Radiation Dermatitis, Radiation Dermatitis Acute
Phase 2CompletedDennis Bregner Zetner482019-04-302021-09-10
Topical Amphotericin B in 30% Dimethylsulphoxide in Treating of Non-dermatophytes Onychomycosis
amphotericin B in 30% DMSO, 30% DMSO - Fungal Infection, Onychomycosis
Phase 4CompletedMahidol University192019-01-152021-09-28
Continuous Alloreactive T Cell Depletion and Regulatory T Cell Expansion for the Treatment of Steroid-refractory or Dependent Chronic GVHD
Autologous peripheral blood mononuclear cells ex vivo depleted for reactive T cells, using TH9402 based photodynamic therapy, in a final formulation of 10% DMSO, 30% autologous plasma in PlasmaLyte. - Chronic GVHD After HCT for Cancer or Immune Disease
Phase 2Unknowndaphne brockington172016-03-012019-08-14
Comparison of the Treatment of Refractory Bladder Pain Syndrome With DMSO and DMSO With Botulinum Toxin A
DMSO, Botox - Bladder Pain Syndrome
Early Phase 1CompletedUniversity of Pennsylvania22015-08-012017-06-09
Protocol for the Infusion of Buffy Coat-derived Cryopreserved Platelets in Patients With Severe Thrombocytopenia
Transfusion of Pooled Platelets Cryopreserved In DMSO - Thrombocytopenia, Primary Thrombocytopenia,Unspecified
Phase 4TerminatedNapolitano Mariasanta52015-07-012017-10-18
Efficacy of Oral Probiotic and Antibiotic Administration in Patients With Chronic Periodontitis
Lactobacillus rhamnosus SP1, Azithromycin, Talc powder - Chronic Periodontitis
Phase 2UnknownUniversity of Chile542015-06-012016-09-27
Phase 1 Safety Study of Dimethyl Sulfoxide Cryopreserved Platelets
CPP, LSP - Thrombocytopenia
Phase 1CompletedU.S. Army Medical Research and Development Command282014-11-052021-05-20
DMSO for Prevention of Capsular Contraction in Alloplastic Breast Reconstruction
Dimethyl Sulfoxide, Saline 0.9% - Breast Capsular Contracture, Dimethyl Sulfoxide
Phase 2 / Phase 3UnknownRabin Medical Center1102014-08-012014-08-01
Efficacy of Oral Probiotic Administration in Patients With Chronic Periodontitis
Lactobacillus rhamnosus SP1, Talc powder, Periodontal treatment - -Chronic Periodontitis
Phase 2UnknownJorge Gamonal362014-06-012016-06-15
Metformin and Dietary Restriction to Prevent Age-related Morbid Events in People With Metabolic Syndrome
Metformin Hydrochloride 850 MG Oral Tablet [Glucophage], Ludipress, mg stereate, micronized hydrated silica, talcum - Metabolic Syndrome
Phase 3CompletedFondazione IRCCS Istituto Nazionale dei Tumori, Milano16002014-02-012021-09-28
Antimicrobial Photodynamic Therapy Applied in Orthodontic. Orthodontic Patients.
Curcumin, LED, Surfactant - Dentist-Patient Relations
Phase 1CompletedUniversity of Sao Paulo242014-01-012015-01-13

Showing 20 of 31. Sign in to see all of them.

Conditions studied

Cystitis, Interstitial (5)  ·  Chronic Periodontitis (2)  ·  Thrombocytopenia (2)  ·  Urinary Bladder, Overactive (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Breast Neoplasms (1)  ·  Carcinoma, Squamous Cell (1)  ·  HIV Infections (1)  ·  Hematoma, Subdural, Chronic (1)  ·  Immune System Diseases (1)  ·  Joint Diseases (1)  ·  Lentivirus Infections (1)  ·  Malocclusion (1)  ·  Melanoma (1)  ·  Metabolic Syndrome (1)

Sponsors

Assaf-Harofeh Medical Center (2)  ·  Mayo Clinic (2)  ·  Al-Azhar University (1)  ·  Cairo University (1)  ·  Center for Biomedical Research, Inc. (1)  ·  Chinese University of Hong Kong (1)  ·  Craig L Slingluff, Jr (1)  ·  Dennis Bregner Zetner (1)  ·  Endeavor Health (1)  ·  Erasme University Hospital (1)  ·  Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (1)  ·  Foundation University Islamabad (1)  ·  Hospital Universitari Vall d'Hebron Research Institute (1)  ·  Jorge Gamonal (1)  ·  Latakia University (1)

Countries

United States (5)  ·  Canada (3)  ·  Egypt (3)  ·  Israel (3)  ·  Chile (2)  ·  Italy (2)  ·  Belgium (1)  ·  Brazil (1)  ·  Denmark (1)  ·  Pakistan (1)  ·  Spain (1)  ·  Syria (1)  ·  Thailand (1)  ·  United Kingdom (1)

Top investigators

Kobi Stav, MD (2)  ·  Aisha Zahran (1)  ·  Alejandro Tomasello, MD (1)  ·  Anne Delbaere, Ph.D. (1)  ·  Ariana Smith, MD (1)  ·  Charussri Leeyaphan, MD (1)  ·  Craig L. Slingluff, MD (1)  ·  David SC Hui, MD (1)  ·  Dennis B Zetner, MD (1)  ·  Franco Berrino, MD (1)  ·  Jerzy Gajewski, MD, FRCSC (1)  ·  Jorge Gamonal, Professor (1)  ·  Jose A Cancelas-Perez, MD, PhD (1)  ·  Jose Luis Cuevas, MD (1)  ·  Mariasanta Napolitano, MD (1)

Results publications

PMID 10233295, PMID 10642676, PMID 14723731, PMID 15183555, PMID 19648387, PMID 20347657, PMID 21820203, PMID 22236569, PMID 22976905, PMID 23416171, PMID 24069230, PMID 24079583, PMID 24124451, PMID 24558525, PMID 24703280, PMID 25013957, PMID 25639524, PMID 26471716, PMID 27799043, PMID 27815659, PMID 28106245, PMID 28740367, PMID 30204953, PMID 30794607, PMID 31753773, PMID 33413320, PMID 33523325, PMID 35333878, PMID 36504246

NIH funding

2008 (1), 2018 (1)